scanX
Home
Aarti Drugs

Aarti Drugs

520.75
+7.55
(1.47%)
Market Cap (₹ Cr.)
₹4,717
52 Week High
635.00
Book Value
₹139
52 Week Low
431.05
PE Ratio
30.07
PB Ratio
3.68
PE for Sector
42.31
PB for Sector
22.11
ROE
13.95 %
ROCE
16.44 %
Dividend Yield
0.19 %
EPS
₹17.06
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-6.83 %
Net Income Growth
3.15 %
Cash Flow Change
169.22 %
ROE
-4.04 %
ROCE
-12.62 %
EBITDA Margin (Avg.)
11.76 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
278
264
258
257
297
269
287
264
272
229
288
308
316
352
320
351
438
370
443
416
416
477
515
476
453
507
512
595
642
551
625
627
697
592
578
540
561
493
Expenses
235
220
216
214
254
225
240
224
225
196
244
257
261
301
274
300
380
318
378
356
339
359
406
374
374
432
442
503
557
496
555
557
608
520
512
478
490
439
EBITDA
43
44
42
42
44
44
48
40
47
33
44
51
55
51
46
51
58
52
65
59
77
117
109
102
79
76
70
92
85
55
70
70
89
73
66
61
70
54
Operating Profit %
15 %
16 %
16 %
15 %
15 %
16 %
16 %
15 %
17 %
14 %
15 %
16 %
17 %
14 %
14 %
15 %
12 %
14 %
15 %
14 %
17 %
24 %
21 %
21 %
17 %
15 %
14 %
15 %
13 %
10 %
11 %
11 %
13 %
12 %
11 %
11 %
12 %
11 %
Depreciation
8
9
9
9
9
9
9
9
9
9
9
9
10
10
10
10
10
11
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
Interest
10
10
11
11
11
9
8
9
8
8
8
8
9
9
9
10
10
9
8
8
7
6
7
5
4
4
5
5
6
7
8
9
8
8
8
7
8
7
Profit Before Tax
25
25
23
22
23
25
30
22
30
16
27
33
37
32
27
31
38
32
46
40
57
99
90
85
63
60
53
75
67
36
50
49
69
53
47
43
50
35
Tax
5
6
6
4
5
6
9
5
6
4
7
8
11
8
7
7
10
9
13
12
16
25
22
23
15
15
13
20
18
9
13
14
18
13
11
11
15
8
Net Profit
19
17
16
17
17
17
20
16
22
11
18
22
23
22
18
21
26
22
31
27
57
73
70
65
50
46
41
56
53
26
37
37
53
40
35
32
36
27
EPS in ₹
7.79
7.04
6.41
6.86
7.07
7.16
8.30
6.93
8.58
4.43
7.56
9.23
9.46
9.40
7.65
8.97
11.31
9.19
13.22
11.48
24.28
31.34
7.49
6.94
5.39
4.90
4.39
6.03
5.72
2.85
3.95
3.96
5.74
4.27
3.75
3.44
3.93
2.93
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
967
1,055
1,116
1,316
1,373
1,471
1,637
2,035
2,196
2,172
Fixed Assets
431
463
542
564
586
612
631
649
634
722
Current Assets
507
542
529
697
735
825
960
1,273
1,350
1,181
Capital Work in Progress
13
34
14
28
32
11
16
60
161
222
Investments
0
0
18
17
19
20
24
28
29
30
Other Assets
522
558
541
707
736
828
966
1,297
1,372
1,198
Total Liabilities
663
704
729
883
854
849
777
1,062
1,081
996
Current Liabilities
464
477
449
589
547
554
522
855
847
685
Non Current Liabilities
199
227
280
294
307
294
256
208
234
312
Total Equity
304
350
387
433
519
622
860
972
1,114
1,175
Reserve & Surplus
279
326
363
410
495
598
766
880
1,022
1,083
Share Capital
24
24
24
24
24
23
93
93
93
92
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
1
-0
-0
1
-1
-0
-1
0
1
Investing Activities
-102
-87
-96
-71
-59
-29
-69
-125
-131
-187
Operating Activities
107
125
174
62
147
196
154
40
162
337
Financing Activities
-5
-37
-78
9
-87
-168
-85
84
-31
-149
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
60.20 %
60.14 %
60.12 %
59.99 %
59.83 %
59.98 %
59.77 %
59.66 %
59.58 %
58.70 %
58.56 %
57.47 %
57.13 %
55.67 %
FIIs
2.99 %
2.57 %
2.21 %
2.03 %
2.07 %
2.07 %
1.94 %
1.90 %
1.94 %
1.96 %
2.33 %
2.10 %
2.56 %
2.96 %
DIIs
1.76 %
2.00 %
2.12 %
2.28 %
2.69 %
2.76 %
3.16 %
3.90 %
4.09 %
4.71 %
5.32 %
5.26 %
5.99 %
7.35 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
35.05 %
35.29 %
35.55 %
35.71 %
35.41 %
35.19 %
35.13 %
34.53 %
34.39 %
34.62 %
33.79 %
35.17 %
34.31 %
34.02 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,919.95 4,62,183.91 43.83 49,887.17 12.06 9,648 42.62 69.11
Divis Laboratories
5,423.80 1,44,579.50 86.37 8,184.00 0.89 1,600 20.79 63.50
Cipla
1,664.85 1,33,571.58 30.05 26,520.66 14.17 4,155 17.77 58.51
Dr Reddys Laboratories
6,749.10 1,12,773.77 20.26 28,905.40 12.36 5,578 -0.90 52.91
Zydus Life Science
1,080.35 1,07,501.01 25.79 19,831.50 13.82 3,831 30.78 42.63
Mankind Pharma
2,578.95 1,01,024.42 51.48 10,615.63 19.57 1,942 9.89 57.29
Lupin
2,194.40 99,904.51 44.14 20,141.50 19.94 1,936 77.69 52.16
Aurobindo Pharma
1,438.30 85,599.77 23.86 29,559.25 17.55 3,169 61.17 35.32
Alkem Laboratories
6,151.25 72,467.15 33.71 12,978.42 9.84 1,811 91.18 54.09
Glenmark Pharmaceuticals
1,666.95 47,227.01 - 12,653.09 6.58 -1,831 96.52 50.20

Corporate Action

Technical Indicators

RSI(14)
Neutral
42.82
ATR(14)
Less Volatile
16.02
STOCH(9,6)
Neutral
32.86
STOCH RSI(14)
Neutral
21.80
MACD(12,26)
Bearish
-2.15
ADX(14)
Weak Trend
14.74
UO(9)
Bearish
48.79
ROC(12)
Downtrend But Slowing Down
-0.80
WillR(14)
Neutral
-60.70
Bearish
5
Neutral
4
Bullish
0
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Technical Screeners
Fundamental Screeners
Candlestick Screeners
Intraday Screeners
Price & Volume Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.